ArticleJournal of Cancer2023

MTA2 is one of 14 Transcription factors predicting recurrence free survival in gastric cancer and promotes cancer progression by targeting MCM5.

Anshu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.